传染病专家对耐药性皮肤癣菌病的认识，美国。
Recognition of Antifungal-Resistant Dermatophytosis by Infectious Diseases Specialists, United States.
出版信息
Emerg Infect Dis. 2024 Sep;30(9):1978-1980. doi: 10.3201/eid3009.240118.
Abstract
Antifungal-resistant dermatophyte infections have recently emerged as a global public health concern. A survey of US infectious diseases specialists found that only 65% had heard of this issue and just 39% knew how to obtain testing to determine resistance. Increased clinician awareness and access to testing for antifungal-resistant dermatophytosis are needed.
摘要
抗真菌药物耐药的皮肤癣菌感染最近已成为全球公共卫生关注的一个问题。一项针对美国传染病专家的调查发现，只有 65%的人听说过这个问题，只有 39%的人知道如何进行检测以确定耐药性。需要提高临床医生的认识，并提供检测抗真菌药物耐药性皮肤癣菌病的途径。
相似文献
1
Recognition of Antifungal-Resistant Dermatophytosis by Infectious Diseases Specialists, United States.传染病专家对耐药性皮肤癣菌病的认识，美国。
Emerg Infect Dis. 2024 Sep;30(9):1978-1980. doi: 10.3201/eid3009.240118.
2
Extensive Dermatophytosis Caused by Terbinafine-Resistant Trichophyton indotineae, France.法国，特比萘芬耐药的堇毛癣菌引起的广泛皮肤癣菌病。
Emerg Infect Dis. 2022 Jan;28(1):229-233. doi: 10.3201/eid2801.210883.
3
Detection of terbinafine-resistant Trichophyton indotineae isolates within the Trichophyton mentagrophytes species complex isolated from patients in Hue City, Vietnam: A comprehensive analysis.越南顺化市从患者中分离出的特比萘芬耐药须癣毛癣菌种复合体中的 Trichophyton indotineae 分离株的检测：综合分析。
Med Mycol. 2024 Aug 2;62(8). doi: 10.1093/mmy/myae088.
4
and other terbinafine-resistant dermatophytes in North America.以及北美洲的其他特比萘芬耐药皮肤癣菌。
J Clin Microbiol. 2023 Dec 19;61(12):e0090323. doi: 10.1128/jcm.00903-23. Epub 2023 Nov 28.
5
Dermatophytosis Caused by Trichophyton indotineae (Trichophyton mentagrophytes ITS Genotype VIII) in Sri Lanka.斯里兰卡由堇青毛癣菌（须癣毛癣菌 ITS 基因分型 8）引起的皮肤癣菌病。
Am J Trop Med Hyg. 2024 Jul 9;111(3):575-577. doi: 10.4269/ajtmh.24-0027. Print 2024 Sep 4.
6
Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates.临床重要皮肤癣菌的抗真菌药物敏感性分析及特比萘芬耐药分离株点突变的检测。
Eur J Clin Microbiol Infect Dis. 2018 Oct;37(10):1841-1846. doi: 10.1007/s10096-018-3317-4. Epub 2018 Jul 7.
7
Potential Sexual Transmission of Antifungal-Resistant Trichophyton indotineae.抗真菌药物耐药的堇毛癣菌可能存在性传播。
Emerg Infect Dis. 2024 Apr;30(4):807-809. doi: 10.3201/eid3004.240115. Epub 2024 Mar 4.
8
Case of tinea corporis due to terbinafine-resistant Trichophyton interdigitale.由对特比萘芬耐药的指间毛癣菌引起的体癣病例。
J Dermatol. 2020 Apr;47(4):e104-e105. doi: 10.1111/1346-8138.15243. Epub 2020 Jan 28.
9
Epidemiological trends, antifungal drug susceptibility and SQLE point mutations in etiologic species of human dermatophytosis in Al-Diwaneyah, Iraq.伊拉克迪瓦尼耶地区人类皮肤癣菌病的病原物种的流行病学趋势、抗真菌药物敏感性和 SQLE 点突变。
Sci Rep. 2024 Jun 3;14(1):12669. doi: 10.1038/s41598-024-63425-w.
10
Evaluation of DermaGenius resistance real-time polymerase chain reaction for rapid detection of terbinafine-resistant Trichophyton species.评估DermaGenius耐药性实时聚合酶链反应用于快速检测对特比萘芬耐药的毛癣菌属菌种。
Mycoses. 2021 Jul;64(7):721-726. doi: 10.1111/myc.13271. Epub 2021 May 18.
本文引用的文献
1
and other terbinafine-resistant dermatophytes in North America.以及北美洲的其他特比萘芬耐药皮肤癣菌。
J Clin Microbiol. 2023 Dec 19;61(12):e0090323. doi: 10.1128/jcm.00903-23. Epub 2023 Nov 28.
2
Terbinafine-Resistant Dermatophytes and the Presence of Trichophyton indotineae in North America.北美地区特比萘芬耐药的皮肤癣菌和堇毛癣菌的存在。
J Clin Microbiol. 2023 Aug 23;61(8):e0056223. doi: 10.1128/jcm.00562-23. Epub 2023 Jul 11.
3
Notes from the Field: First Reported U.S. Cases of Tinea Caused by Trichophyton indotineae - New York City, December 2021-March 2023.实地记录：美国首次报告由印多蒂毛癣菌引起的癣病例——纽约市，2021年12月至2023年3月
MMWR Morb Mortal Wkly Rep. 2023 May 12;72(19):536-537. doi: 10.15585/mmwr.mm7219a4.
4
Effect of Different Itraconazole Dosing Regimens on Cure Rates, Treatment Duration, Safety, and Relapse Rates in Adult Patients With Tinea Corporis/Cruris: A Randomized Clinical Trial.不同伊曲康唑给药方案对成年体股癣患者治愈率、治疗时长、安全性及复发率的影响：一项随机临床试验
JAMA Dermatol. 2022 Sep 14;158(11):1269-78. doi: 10.1001/jamadermatol.2022.3745.
5
Healthcare Provider Testing Practices for Tinea and Familiarity with Antifungal-Drug-Resistant Tinea-United States, 2022.2022年美国医疗服务提供者针对癣的检测实践及对抗真菌药物耐药癣的熟悉程度
J Fungi (Basel). 2022 Aug 9;8(8):831. doi: 10.3390/jof8080831.
6
The unprecedented epidemic-like scenario of dermatophytosis in India: I. Epidemiology, risk factors and clinical features.前所未有的皮肤病癣菌病在印度的流行情况：I. 流行病学、危险因素和临床特征。
Indian J Dermatol Venereol Leprol. 2021 Mar-Apr;87(2):154-175. doi: 10.25259/IJDVL_301_20.
7
The Growing Problem of Antifungal Resistance in Onychomycosis and Other Superficial Mycoses.甲真菌病和其他浅部真菌病中抗真菌耐药性日益严重的问题。
Am J Clin Dermatol. 2021 Mar;22(2):149-157. doi: 10.1007/s40257-020-00580-6. Epub 2020 Dec 22.
8
Treatment-resistant dermatophytosis: A representative case highlighting an emerging public health threat.难治性皮肤癣菌病：一个凸显新出现的公共卫生威胁的典型病例
JAAD Case Rep. 2020 Jun 3;6(11):1153-1155. doi: 10.1016/j.jdcr.2020.05.025. eCollection 2020 Nov.
9
Indian Trichophyton mentagrophytes squalene epoxidase erg1 double mutants show high proportion of combined fluconazole and terbinafine resistance.印度须癣毛癣菌角鲨烯环氧酶erg1双突变体对氟康唑和特比萘芬联合耐药比例高。
Mycoses. 2020 Nov;63(11):1175-1180. doi: 10.1111/myc.13150. Epub 2020 Sep 23.
10
Dermatophytosis: the management of fungal infections.皮肤癣菌病：真菌感染的管理
Skinmed. 2005 Sep-Oct;4(5):305-10. doi: 10.1111/j.1540-9740.2005.03435.x.
Zotero 插件